Chemed Corp
(FRA:CXM)
€
545
5 (0.93%)
Market Cap: 8.30 Bil
Enterprise Value: 8.23 Bil
PE Ratio: 30.27
PB Ratio: 7.41
GF Score: 95/100 Chemed Corp at Oppenheimer Healthcare Conference (Virtual) Transcript
Mar 17, 2021 / 12:40PM GMT
Release Date Price:
€372
(-2.11%)
Michael David Wiederhorn
Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst
Good morning. Welcome to Oppenheimer's 31st Annual Healthcare Conference. I'm Michael Wiederhorn. I cover the payers and provider space.
Presenting today is Chemed. We have President and CEO, Kevin McNamara; and Chief Financial Officer, David Williams. We'll do -- we'll be doing this fireside, so I'll just kind of shoot right into the questions here.
Welcome, guys. Hopefully, next year -- like I said, hopefully, next year, we'll be back in person and be breaking bread together.
Questions & Answers
Michael David Wiederhorn
Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst
So first question, can you discuss the factors affecting your hospice census and the time line for that to be fixed in your view?
Kevin J. McNamara
Chemed Corporation - CEO, President & Director
Well, let me start, Mike. Clearly, when we look at what we've been saying for some time externally and
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot